Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Leading scientists to discuss research applications for therapeutic cloning

21.10.2004


University of Pittsburgh’s Gerald Schatten, Ph.D., joins South Korean researchers for symposium at 60th Annual Meeting of the American Society for Reproductive Medicine



As members of the United Nations General Assembly are soon to vote on the future of cloning research, possibly within days, leading scientists will be conducting a symposium discussion on the status of current work in cloning and its potential for the emerging field of regenerative medicine.

Gerald Schatten, Ph.D., professor of obstetrics, gynecology and reproductive sciences and cell biology and physiology at the University of Pittsburgh School of Medicine, will join South Korean researchers Woo Suk Hwang, D.V.M., Ph.D., and Shin Yong Moon, M.D., in a panel discussion of scientific and ethical issues surrounding cloning research on Wednesday, Oct. 20, at the 60th annual meeting of the American Society for Reproductive Medicine. Scientific sessions will take place Oct. 16-20 at the Pennsylvania Convention Center in Philadelphia.


In February, Drs. Hwang and Moon from Seoul National University, reported the successful harvesting of human embryonic stem cells from a cloned embryo. The cloning symposium, called "Assisted Regenerative Medicine: The Future of ART?" and chaired by Linda Giudice, M.D., Ph.D., of Stanford University, will take place on Wednesday, Oct. 20. "Human reproductive cloning is unsafe, unethical and ought to be illegal everywhere in the world," said Dr. Schatten, who also is director of the Pittsburgh Development Center at the Magee-Womens Research Institute. "But a ban on all forms of human cloning sends the wrong signal to the scientific community; it stigmatizes the research and will slow the pace of discoveries for decades to come."

Dr. Schatten, who testified before U.N. delegates on the issue in June, is close to the debate because he has been trying to clone primates, which belong to the same overall species classification as humans. The implications of any success for the prospects of human cloning are clear, and Dr. Schatten is exploring ways to make sure that if he succeeds, others won’t be able to use his work to advance human cloning for reproductive purposes.

In the U.N., the United States is pressing for a ban on all forms of human cloning, while Belgium heads a faction seeking a ban on reproductive cloning but with the option for countries to approve therapeutic cloning. In 2001, Britain became the first country to legalize research cloning. Researchers hope stem cells derived from therapeutic cloning research will revolutionize medicine by providing better treatments for disorders such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, heart disease, stroke, diabetes, spinal cord injuries and genetic diseases.

While the hopes are real, scientific findings remain ambiguous concerning actual benefits for patients using stem cells for therapeutic purposes. "Will therapeutic cloning create immune matching? It’s unclear. At this point, we don’t even know if human embryonic stem cells are safe, let alone effective," said Dr. Schatten. "What’s important is that research be allowed to continue so we can find out."

Currently, conflicting policies internationally allow different stages of research in human and animal cloning in different countries. The United Kingdom restricts animal work but allows research on human embryos. In the United States, animal work is allowed but work on human embryonic stem cells is restricted to cell lines in existence prior to Aug. 9, 2001. Related legislation varies from state to state, with Pennsylvania being among the most restrictive. South Korea allows therapeutic cloning research but human reproductive cloning is illegal there.

"Perhaps, in a similar fashion to debates surrounding organ donation, it will be challenging to achieve political consensus until the therapeutic benefits of cloning research are clearly demonstrated," said Dr. Schatten, calling for responsible legislation in the United States and warning that a ban on all cloning research could simply move the science offshore or to privately funded efforts not subject to U.S. regulation. Responsible clinical trials also need to be held soon, perhaps by 2008, Dr. Schatten adds.

Michele Baum | EurekAlert!
Further information:
http://upmc.edu

More articles from Life Sciences:

nachricht Could this protein protect people against coronary artery disease?
17.11.2017 | University of North Carolina Health Care

nachricht Microbial resident enables beetles to feed on a leafy diet
17.11.2017 | Max-Planck-Institut für chemische Ökologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

NASA detects solar flare pulses at Sun and Earth

17.11.2017 | Physics and Astronomy

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

17.11.2017 | Health and Medicine

The importance of biodiversity in forests could increase due to climate change

17.11.2017 | Studies and Analyses

VideoLinks
B2B-VideoLinks
More VideoLinks >>>